Testing effectiveness (Phase 2)Not Yet RecruitingNCT06771154
What this trial is testing
Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial
Who this might be right for
Recurrent/Metastatic Endometrial Cancer
Peking Union Medical College Hospital 140